{
    "clinical_study": {
        "@rank": "43367", 
        "arm_group": {
            "arm_group_label": "Ovarian tissue cryopreservation", 
            "arm_group_type": "Experimental", 
            "description": "The ovarian tissue is cryopreserved and stored at Boston IVF, which is an FDA compliant and American Association of Tissue Banks accredited long term storage facility for reproductive tissue."
        }, 
        "brief_summary": {
            "textblock": "To provide a novel fertility preservation option for patients facing a fertility threatening\n      cancer diagnosis or treatment regimen by establishing an ovarian tissue cryopreservation\n      program. To determine if ovarian tissue cryopreservation provides women with a useful,\n      successful option for fertility preservation\n\n      The hypothesis is that ovarian tissue cryopreservation for fertility preservation provides\n      an alternative option for fertility preservation."
        }, 
        "brief_title": "Ovarian Tissue Cryopreservation for Fertility Preservation", 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Will undergo surgery, chemotherapy, drug treatment and/or radiation for the treatment\n             or prevention of a medical condition or malignancy which are likely to result in\n             permanent loss of subsequent ovarian function or diminished fertility\n\n          -  Have a medical condition or malignancy that requires removal of all or part of one or\n             both ovaries\n\n          -  Patients may have newly diagnosed or recurrent disease\n\n          -  Be in good health so as to be able to undergo laparoscopic surgery as determined by\n             history and physical examinations, and consultation with the medical oncologist,\n             reproductive endocrinologist, surgeon and anesthesiologist\n\n        Exclusion Criteria:\n\n          -  Moderate to high-risk of ovarian failure due to treatment\n\n          -  Documented ovarian metastasis\n\n          -  HIV or hepatitis (B, C)-positive serology\n\n          -  Absolute surgical contraindications\n\n          -  ECOG performance status of 0 or 1\n\n          -  Pregnancy\n\n          -  Women with psychological, psychiatric, or other conditions which prevent giving fully\n             informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682525", 
            "org_study_id": "N09-454"
        }, 
        "intervention": {
            "arm_group_label": "Ovarian tissue cryopreservation", 
            "description": "Use of ovarian tissue cryopreserved and stored at Boston IVF", 
            "intervention_name": "Frozen ovarian tissue", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fertility preservation", 
            "Ovarian Tissue", 
            "Cryopreservation", 
            "Assisted Reproductive Technology"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "link": {
            "url": "http://www.bostonivf.com"
        }, 
        "location": [
            {
                "contact": {
                    "email": "SNMORRIS@PARTNERS.ORG", 
                    "last_name": "Stephanie Morris, MD", 
                    "phone": "617-243-5205"
                }, 
                "facility": {
                    "address": {
                        "city": "Newton", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02462"
                    }, 
                    "name": "Newton Wellesley Hospital"
                }, 
                "investigator": {
                    "last_name": "Stephanie Morris, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dryley@bostonivf.com", 
                    "last_name": "David Ryley, MD", 
                    "phone": "617-735-9000"
                }, 
                "facility": {
                    "address": {
                        "city": "Waltham", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02451"
                    }, 
                    "name": "Boston IVF"
                }, 
                "investigator": {
                    "last_name": "David Ryley, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ovarian Tissue Cryopreservation for Fertility Preservation", 
        "overall_contact": {
            "email": "dryley@bostonivf.com", 
            "last_name": "David Ryley, MD", 
            "phone": "617-735-9000"
        }, 
        "overall_contact_backup": {
            "email": "SNMORRIS@PARTNERS.ORG", 
            "last_name": "Stephanie Morris, MD", 
            "phone": "617-243-5205"
        }, 
        "overall_official": {
            "affiliation": "Boston IVF", 
            "last_name": "David Ryley, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety, which will be assessed by tracking the number of minor and major complications of the procedure including the following:\nMinor: Local infection\nMajor: Blood loss requiring blood transfusion, major infection requiring admission or parental antibiotics, injury to surrounding organs requiring further procedures, hospitalization due to unforeseen operative complication", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "10 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682525"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Boston IVF", 
            "investigator_full_name": "David Ryley, MD", 
            "investigator_title": "Reproductive Endocrinologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Proportion of women who attempt pregnancy\nProportion of women who become pregnant and outcome\nProportion of women using assisted reproduction after re-implantation or ovarian tissue.\nMenstrual cyclicity and ovarian reserve in those with and without re-implantation", 
            "measure": "Efficacy", 
            "safety_issue": "No", 
            "time_frame": "10 years"
        }, 
        "source": "Boston IVF", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boston IVF", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}